X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3236) 3236
Publication (293) 293
Book Review (22) 22
Book Chapter (16) 16
Conference Proceeding (9) 9
Dissertation (9) 9
Magazine Article (5) 5
Book / eBook (1) 1
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2083) 2083
humans (2044) 2044
animals (1229) 1229
diabetes mellitus, type 2 - drug therapy (1186) 1186
glucose (1062) 1062
male (1033) 1033
sodium-glucose transporter 2 - antagonists & inhibitors (965) 965
diabetes (867) 867
hypoglycemic agents - therapeutic use (825) 825
type 2 diabetes (736) 736
female (725) 725
endocrinology & metabolism (704) 704
dapagliflozin (571) 571
dextrose (571) 571
diabetes mellitus (552) 552
glucose - metabolism (552) 552
glucosides - therapeutic use (527) 527
middle aged (499) 499
sodium (493) 493
pharmacology & pharmacy (473) 473
double-blind (467) 467
sodium-glucose transporter 2 - metabolism (450) 450
canagliflozin (434) 434
rats (421) 421
insulin (413) 413
hypoglycemic agents - adverse effects (405) 405
sodium-glucose transporter 1 - metabolism (401) 401
hypoglycemic agents - pharmacology (394) 394
empagliflozin (377) 377
benzhydryl compounds - therapeutic use (357) 357
treatment outcome (356) 356
hyperglycemia (345) 345
blood glucose - metabolism (332) 332
aged (329) 329
mice (328) 328
type 2 diabetes mellitus (327) 327
diabetes mellitus, type 2 - blood (319) 319
sglt2 inhibitor (319) 319
adult (305) 305
glucosides - pharmacology (301) 301
physiology (300) 300
sodium-glucose transporter 1 (300) 300
metformin (294) 294
analysis (291) 291
glycemic control (289) 289
safety (289) 289
sodium-glucose transporter 2 inhibitors - therapeutic use (289) 289
blood glucose - drug effects (286) 286
hypoglycemic agents (284) 284
risk factors (280) 280
diabetes mellitus, type 2 - metabolism (267) 267
diabetes mellitus, type 2 - complications (265) 265
type-2 diabetes-mellitus (259) 259
glucosides - adverse effects (256) 256
sglt2 inhibitors (249) 249
blood pressure (246) 246
hypoglycemic agents - administration & dosage (244) 244
glucose metabolism (243) 243
mellitus (236) 236
expression (234) 234
sodium-glucose transporter 2 inhibitors (229) 229
care and treatment (228) 228
clinical trials (228) 228
biochemistry & molecular biology (226) 226
efficacy (224) 224
inadequate glycemic control (222) 222
internal medicine (215) 215
sodium-glucose transporter 1 - genetics (213) 213
research (212) 212
abridged index medicus (211) 211
kidney - metabolism (206) 206
drug therapy (199) 199
monosaccharide transport proteins - metabolism (199) 199
medicine & public health (197) 197
kidney (196) 196
glucose transporter (195) 195
medicine, general & internal (195) 195
heart failure (193) 193
metabolism (190) 190
cardiac & cardiovascular systems (189) 189
sglt2 (188) 188
body weight (185) 185
benzhydryl compounds - pharmacology (181) 181
sglt1 (181) 181
drug therapy, combination (179) 179
benzhydryl compounds - adverse effects (174) 174
inhibitors (173) 173
mortality (172) 172
rodents (168) 168
membrane glycoproteins - metabolism (167) 167
diabetes therapy (163) 163
dose-response relationship, drug (162) 162
glucosides - administration & dosage (162) 162
dipeptidyl-peptidase iv inhibitors - therapeutic use (159) 159
kidney - drug effects (159) 159
risk (158) 158
blood-pressure (157) 157
insulin resistance (157) 157
sodium - metabolism (156) 156
diabetes mellitus, type 2 - physiopathology (152) 152
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3103) 3103
German (49) 49
Japanese (46) 46
Spanish (27) 27
French (18) 18
Korean (17) 17
Russian (11) 11
Chinese (9) 9
Czech (5) 5
Danish (4) 4
Dutch (3) 3
Italian (3) 3
Polish (3) 3
Hungarian (2) 2
Portuguese (2) 2
Hebrew (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1322 - 1326
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1289 - 1294
Aim To quantify the expression of sodium‐glucose co‐transporter (SGLT)2 and SGLT1, their cognate basolateral transporters, GLUT2 and GLUT1, and the... 
clinical physiology | SGLT2 inhibitor | type 2 diabetes | RAT | TRANSPORTERS | ALBUMINURIA | PROXIMAL TUBULAR CELLS | GLOMERULAR HYPERFILTRATION | NEPHROPATHY | HYPERGLYCEMIA | PROTEIN EXPRESSION | ENDOCRINOLOGY & METABOLISM | BRUSH-BORDER MEMBRANE | KIDNEY | Kidney Tubules - physiopathology | Kidney - pathology | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Kidney Neoplasms - surgery | Kidney - metabolism | Carcinoma - complications | Kidney Neoplasms - physiopathology | Nephrectomy | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Female | Retrospective Studies | Sodium-Glucose Transporter 1 - metabolism | Kidney Tubules - pathology | Carcinoma - pathology | Kidney Neoplasms - complications | Kidney Tubules - metabolism | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Sodium-Glucose Transporter 2 - genetics | Hypoglycemic Agents - therapeutic use | Reproducibility of Results | Glomerular Filtration Rate | Kidney - drug effects | Kidney Tubules - drug effects | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Sodium-Glucose Transporter 2 - metabolism | Carcinoma - surgery | Carcinoma - physiopathology | Gene Expression Regulation - drug effects | Kidney Neoplasms - pathology | Aged | Diabetes Mellitus, Type 2 - pathology | Diabetes Mellitus, Type 2 - drug therapy | Neoplasm Staging | Type 2 diabetes | Immunohistochemistry | Viral antibodies | Care and treatment | Antibodies | Glucose | Muscle proteins | Dextrose | Diabetes
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2018, Volume 20, Issue 2, pp. 458 - 462
Journal Article
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 10/2013, Volume 170, Issue 3, pp. 519 - 531
Background and Purpose Although inhibition of renal sodium–glucose co‐transporter 2 (SGLT2) has a stable glucose‐lowering effect in patients with type 2... 
tofogliflozin | nephropathy | beta‐cell loss | sodium–glucose co‐transporter inhibitor | sodium-glucose co-transporter inhibitor | beta-cell loss | SYSTEM | METFORMIN | SELECTIVE SGLT2 INHIBITOR | GLYCEMIC CONTROL | EFFICACY | DAPAGLIFLOZIN TREATMENT | GLOMERULAR HYPERFILTRATION | DIABETES-MELLITUS | INSULIN | PHARMACOLOGY & PHARMACY | KIDNEY | Kidney - pathology | Diabetic Nephropathies - etiology | Glycated Hemoglobin A - metabolism | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Angiotensin II Type 1 Receptor Blockers - pharmacology | Insulin-Secreting Cells - metabolism | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Time Factors | Female | Albuminuria - metabolism | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Disease Models, Animal | Glucosides - pharmacology | Kidney - drug effects | Sodium-Glucose Transporter 2 - metabolism | Diabetic Nephropathies - metabolism | Losartan - pharmacology | Biomarkers - blood | Albuminuria - prevention & control | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Animals | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Benzhydryl Compounds - pharmacology | Mice | Insulin-Secreting Cells - pathology | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Glucose metabolism | Pancreatic beta cells | Image processing | Blood sugar | Analysis | Angiotensin | Equipment and supplies | Glucose | Diabetes | Sodium | Pancreas | Insulin | Rodents | Research Papers | sodium–glucose co-transporter inhibitor
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 06/2013, Volume 53, Issue 6, pp. 601 - 610
Journal Article
by McMurray, John J.V and DeMets, David L and Inzucchi, Silvio E and Køber, Lars and Kosiborod, Mikhail N and Langkilde, Anna M and Martinez, Felipe A and Bengtsson, Olof and Ponikowski, Piotr and Sabatine, Marc S and Sjöstrand, Mikaela and Solomon, Scott D and McMurray, John JV and DeMets, David L and Inzucchi, Silvio E and Køber, Lars and Kosiborod, Mikhail N and Langkilde, Anna Maria and Martinez, Felipe A and Ponikowski, Piotr and Sabatine, Marc S and Sjöstrand, Mikaela and Solomon, Scott D and Diez, Mirta and Nicolau, Jose and Katova, Tzvetana and O'Meara, Eileen and Howlett, Jonathan and Verma, Subodh and Ge, Junbo and Belohlavek, Jan and Schou, Morten and Böhm, Michael and Merkely, Bela and Chopra, Vijay and Kitakaze, Masafumi and de Boer, Rudolf A and Drozdz, Jaroslaw and Tereshchenko, Sergey and Dukat, Andrej and Ljungman, Charlotta and Chiang, Chern‐En and Petrie, Mark and Desai, Akshay and Anand, Inder and Pham, Vinh Nguyen and Pfeffer, Marc A and Pocock, Stuart and Swedberg, Karl and Rouleau, Jean L and Chaturvedi, Nishi and Ivanovich, Peter and Levey, Andrew S and Christ‐Schmidt, Heidi and Held, Claes and Varenhorst, Christoph and Christersson, Christina and Mann, Johannes and Holmgren, Pernilla and Hallberg, Theresa and Langkilde, AnnaMaria and Sjöstrand, Mikaela and Denison, Hans and Reicher, Barry and Bengtsson, Olof and Fox, Ywonne and Forsby, Mikael and Alenhag, Eva‐Lena and Nilsson, Ann and Kazanowska, Kinga and Olofsson, Eva Lavik and Karup, Cathrine and Ekedahl‐Berggren, Maria and Klockargård, Anna‐Lena and Kempe, Karin and Selvén, Mathilda and DAPA-HF Comm Investigators and DAPA-HF Committees and Investigators and on behalf of the DAPA‐HF Committees and Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala kliniska forskningscentrum (UCR)
European Journal of Heart Failure, ISSN 1388-9842, 05/2019, Volume 21, Issue 5, pp. 665 - 675
Journal Article